Table 5.
Results from Tukey HSD comparisons for biomarkers at designated timepoints between patients with mTBI without somatic injuries (mTBI–), patients with mTBI with somatic injuries (mTBI+), trauma controls (TC), and community controls (CC).
Biomarkers | GFAP—acute | GFAP–72 h | NFL–2 weeks | NFL–3 months | Tau—acute |
---|---|---|---|---|---|
Estimate‡ (95% CI) | Estimate‡ (95% CI) | Estimate‡ (95% CI) | Estimate‡ (95% CI) | Estimate‡ (95% CI) | |
p-value | p-value | p-value | p-value | p-value | |
TC: CC | 0.02 (−0.43 to 0.47) | −0.05 (−0.18 to 0.09) | −0.11 (−0.38 to 0.16) | ||
p = 0.99 | p = 0.83 | p = 0.70 | |||
mTBI–: CC | 0.73 (0.51 to 0.95) | 0.14 (0.03 to 0.25) | 0.13 (0.01 to 0.27) | ||
p < 0.0001 | p = 0.008 | p = 0.03 | |||
mTBI+: CC | 1.07 (0.82 to 1.31) | 0.28 (0.16 to 0.41) | 0.25 (0.10 to 0.39) | ||
p < 0.0001 | p < 0.0001 | p = 0.0001 | |||
mTBI–: TC | 0.71 (0.24 to 1.18) | 0.42 (−0.15 to 0.99) | 0.31 (−0.07 to 0.68) | 0.18 (0.05 to 0.31) | 0.25 (−0.03 to 0.53) |
p = 0.0008 | p = 0.20 | p = 0.13 | p = 0.002 | p = 0.09 | |
mTBI+: TC | 1.05 (0.56 to 1.53) | 0.64 (0.06 to 1.22) | 0.63 (0.24 to 1.01) | 0.33 (0.19 to 0.47) | 0.36 (0.07 to 0.65) |
p < 0.0001 | p = 0.03 | p = 0.0005 | p < 0.0001 | p = 0.009 | |
mTBI+: mTBI– | 0.33 (0.05 to 0.62) | 0.22 (0.01 to 0.43) | 0.32 (0.14 to 0.51) | 0.15 (0.03 to 0.26) | 0.11 (−0.06 to 0.28) |
p = 0.01 | p = 0.04 | p = 0.0002 | p = 0.008 | p = 0.36 |
Estimate refers to mean log-transformed group differences as estimated by Tukey's HSD; 95% CI is the 95% confidence interval of the estimated group difference. Significant differences are bolded.
mTBI, mild traumatic brain injury; GFAP, Glial fibrillary acidic protein; NFL, Neurofilament light; TC, Trauma controls; CC, Community control.